Kistler-Tiffany Companies, LLC - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 228 filers reported holding SAGE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 2.20 and the average weighting 0.1%.

Quarter-by-quarter ownership
Kistler-Tiffany Companies, LLC ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$4,702
+12.1%
1000.0%0.00%0.0%
Q1 2023$4,196
+10.0%
1000.0%0.00%0.0%
Q4 2022$3,814
-4.6%
1000.0%0.00%0.0%
Q3 2022$4,000
+33.3%
1000.0%0.00%0.0%
Q2 2022$3,0000.0%1000.0%0.00%0.0%
Q1 2022$3,000
-25.0%
1000.0%0.00%0.0%
Q4 2021$4,0000.0%1000.0%0.00%0.0%
Q3 2021$4,000
-33.3%
1000.0%0.00%0.0%
Q2 2021$6,000
-14.3%
1000.0%0.00%
-50.0%
Q1 2021$7,000
-22.2%
1000.0%0.00%
-33.3%
Q4 2020$9,000
+50.0%
1000.0%0.00%
+50.0%
Q3 2020$6,000
+50.0%
1000.0%0.00%
+100.0%
Q2 2020$4,000
-42.9%
1000.0%0.00%
-50.0%
Q1 2020$7,0000.0%1000.0%0.00%0.0%
Q4 2019$7,000
-50.0%
1000.0%0.00%
-60.0%
Q3 2019$14,000
-22.2%
1000.0%0.01%
-28.6%
Q2 2019$18,000
+12.5%
1000.0%0.01%0.0%
Q1 2019$16,000
+60.0%
1000.0%0.01%
+40.0%
Q4 2018$10,000100
+2400.0%
0.01%
Q4 2014$040.0%0.00%
Q3 2014$040.00%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Finepoint Capital LP 475,600$15,362,0005.31%
Integral Health Asset Management, LLC 412,257$13,316,0002.74%
Palo Alto Investors LP 851,409$27,501,0002.40%
Boxer Capital, LLC 1,094,000$35,336,0002.24%
DAFNA Capital Management LLC 180,306$5,824,0001.59%
Ikarian Capital, LLC 250,000$8,075,0001.47%
Bellevue Group AG 2,973,178$96,034,0001.36%
SECTOR GAMMA AS 118,476$3,827,0000.86%
Artal Group S.A. 450,000$14,535,0000.78%
Diametric Capital, LP 19,393$626,0000.46%
View complete list of SAGE THERAPEUTICS INC shareholders